A study for a 48 year old woman who takes Tamoxifen Citrate - from FDA reports

Summary

3,324 females aged 48 (±5) who take the same drug are studied. This is a personalized study for a 48 year old female patient who has Breast Cancer. The study is created by eHealthMe based on reports from FDA.



How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

What are the drugs?

What are the conditions?

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Jul, 21, 2018

3,324 females aged 48 (±5) who take Tamoxifen Citrate are studied.


Number of reports submitted per year:

Tamoxifen Citrate for a 48-year old woman.

Information of the patient in this study:

  • Age: 48
  • Gender: female
  • Conditions: Breast Cancer
  • Drugs taken:
    • Tamoxifen Citrate (tamoxifen citrate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Nausea (feeling of having an urge to vomit)
  2. Pain in extremity
  3. Weakness
  4. Electrocardiogram qt prolonged
  5. Wound infection
  6. Wound secretion
  7. Jaundice - yellow skin (a yellowish pigmentation of the skin)
  8. Bone pain
  9. Muscle spasms (muscle contraction)
  10. Thyroiditis (inflammation of thyroid gland)
1 - 6 months:
  1. Insomnia (sleeplessness)
  2. Hot flush (sudden feelings of heat)
  3. Constipation
  4. Fatigue (feeling of tiredness)
  5. High blood pressure
  6. Dizziness
  7. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Fever
  10. Pain in extremity
6 - 12 months:
  1. Gums - swollen
  2. Headache (pain in head)
  3. Aseptic necrosis (the death of bone tissue due to a lack of blood supply)
  4. Hair loss
  5. Osteonecrosis of jaw (death of bone of jaw)
  6. Nail abnormalities (abnormal nail)
  7. Swelling
  8. Cancer pain
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Lung neoplasm malignant (cancer tumour of lung)
1 - 2 years:
  1. Depression
  2. Fatigue (feeling of tiredness)
  3. Aseptic necrosis (the death of bone tissue due to a lack of blood supply)
  4. Nausea (feeling of having an urge to vomit)
  5. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  6. Metastases to bone (cancer spreads to bone)
  7. Menopausal symptoms
  8. Impaired healing
  9. Muscle spasms (muscle contraction)
  10. Feeling abnormal
2 - 5 years:
  1. Joint pain
  2. Breathing difficulty
  3. Metastases to bone (cancer spreads to bone)
  4. Hair loss
  5. Muscle aches (muscle pain)
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Weight increased
  8. Impaired healing
  9. High blood cholesterol
  10. Rashes (redness)
5 - 10 years:
  1. Fever
  2. Osteomyelitis (infection of bone)
  3. Bone scan abnormal
  4. Dizziness
  5. Injury
  6. Bone density decreased
  7. Bone disorder
  8. Pain
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Pain in extremity
10+ years:
  1. Breast cancer recurrent
  2. Bone pain
  3. High blood cholesterol
  4. Breathing difficulty
  5. Muscle aches (muscle pain)
  6. Pain in extremity
  7. Dysstasia (difficulty in standing)
  8. Joint pain
not specified:
  1. Pain
  2. Bone disorder
  3. Stress and anxiety
  4. Joint pain
  5. Osteonecrosis of jaw (death of bone of jaw)
  6. Metastases to bone (cancer spreads to bone)
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Anaemia (lack of blood)
  10. Depression

Top conditions involved for these people *:

  1. Metastases To Bone (cancer spreads to bone): 203 people, 6.11%
  2. Depression : 185 people, 5.57%
  3. Breast Cancer Metastatic : 168 people, 5.05%
  4. Pain : 108 people, 3.25%
  5. Neoplasm Malignant (cancer tumour): 94 people, 2.83%
  6. Preventive Health Care : 89 people, 2.68%
  7. High Blood Pressure : 88 people, 2.65%
  8. Stress And Anxiety : 71 people, 2.14%
  9. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 66 people, 1.99%
  10. Chemotherapy : 45 people, 1.35%

Top co-used drugs for these people *:

  1. Zometa (539 people, 16.22%)
  2. Aredia (324 people, 9.75%)
  3. Arimidex (288 people, 8.66%)
  4. Herceptin (271 people, 8.15%)
  5. Taxotere (261 people, 7.85%)
  6. Zoladex (260 people, 7.82%)
  7. Femara (254 people, 7.64%)
  8. Xeloda (213 people, 6.41%)
  9. Cyclophosphamide (204 people, 6.14%)
  10. Taxol (194 people, 5.84%)

* Some reports may have incomplete information.

What is next?

You are not alone:


Related publications that referenced our studies



Related studies:



FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.